Market Closed - Nasdaq Stockholm 11:29:44 2024-05-28 am EDT 5-day change 1st Jan Change
9.29 SEK +1.86% Intraday chart for OssDsign AB +2.20% +16.12%
Sales 2023 112M 10.62M Sales 2024 * 128M 12.08M Capitalization 891M 84.31M
Net income 2023 -130M -12.31M Net income 2024 * -55M -5.21M EV / Sales 2023 5.54 x
Net cash position 2023 160M 15.17M Net cash position 2024 * 94M 8.9M EV / Sales 2024 * 6.24 x
P/E ratio 2023
-5 x
P/E ratio 2024 *
-16.1 x
Employees 41
Yield 2023 *
-
Yield 2024 *
-
Free-Float 50.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.21%
1 week+1.54%
Current month-5.24%
1 month-5.33%
3 months+5.85%
6 months+32.61%
Current year+15.38%
More quotes
1 week
8.74
Extreme 8.74
9.85
1 month
8.74
Extreme 8.74
10.44
Current year
7.78
Extreme 7.78
10.94
1 year
4.53
Extreme 4.53
10.94
3 years
2.61
Extreme 2.605
10.94
5 years
2.61
Extreme 2.605
25.00
10 years
2.61
Extreme 2.605
26.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 20-08-31
Director of Finance/CFO 61 19-12-31
Chief Operating Officer 51 15-12-31
Members of the board TitleAgeSince
Chairman 64 16-04-19
Director/Board Member 59 14-12-31
Director/Board Member 60 18-12-31
More insiders
Date Price Change Volume
24-05-28 9.29 +1.86% 225 120
24-05-27 9.12 -5.98% 309,523
24-05-24 9.7 +2.97% 301,824
24-05-23 9.42 +6.44% 330,292
24-05-22 8.85 -2.64% 170,285

Delayed Quote Nasdaq Stockholm, May 28, 2024 at 05:54 am EDT

More quotes
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings